Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of April 2025. The report specifically details a transaction in the company's own shares executed under a share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity and capital structure updates.
- Shares Purchased: 855,279 ordinary shares
- Purchase Date: April 15, 2025
- Highest Price Paid: 381.20 pence per share
- Lowest Price Paid: 377.10 pence per share
- Volume Weighted Average Price: 379.18 pence per share
- Registered Share Capital: 9,028,701,792 ordinary shares of £0.01 each
- Treasury Shares Held: 4,080,205
- Voting Shares Outstanding: 9,024,621,587
Material Changes
Following the settlement of the April 15 transaction, the company's share capital structure was updated. The number of ordinary shares with voting rights is now 9,024,621,587. This figure is material for shareholders determining notification requirements under the FCA's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. It includes a standard disclaimer stating the announcement does not constitute an offer or solicitation for securities. A full breakdown of individual trades is referenced as available via the London Stock Exchange to comply with the Market Abuse Regulation.
Investor Verification Checklist
- Verify the total number of shares repurchased under the March 28, 2025 programme to date.
- Confirm the updated number of voting shares (9,024,621,587) for disclosure threshold calculations.
- Review the full trade breakdown at the provided RNS link for granular execution details.
- Check the company website for further updates on the remaining capacity of the buyback programme.